Hide metadata

dc.contributor.authorBækkelund, Harald
dc.contributor.authorUlvenes, Pål
dc.contributor.authorBoon-Langelaan, Suzette
dc.contributor.authorArnevik, Espen A.
dc.date.accessioned2022-05-17T05:03:24Z
dc.date.available2022-05-17T05:03:24Z
dc.date.issued2022
dc.identifier.citationBMC Psychiatry. 2022 May 16;22(1):338
dc.identifier.urihttp://hdl.handle.net/10852/94155
dc.description.abstractBackground Patients with complex dissociative disorders (CDD) report high levels of childhood- abuse experiences, clinical comorbidity, functional impairment, and treatment utilization. Although a few naturalistic studies indicate that these patients can benefit from psychotherapy, no randomized controlled trials have been reported with this patient-group. The current study evaluates a structured protocolled group treatment delivered in a naturalistic clinical setting to patients with CDD, as an add-on to individual treatment. Methods Fifty nine patients with CDD were randomized to 20 sessions of stabilizing group–treatment, conjoint with individual therapy, or individual therapy alone, in a delayed-treatment design. The treatment was based on the manual Coping with Trauma-Related Dissociation. The primary outcome was Global Assessment of Functioning (GAF), while secondary outcomes were PTSD and dissociative symptoms, general psychopathology, and interpersonal difficulties. Results Mixed effect models showed no condition x time interaction during the delayed treatment period, indicating no immediate differences between conditions in the primary outcome. Similar results were observed for secondary outcomes. Within-group effects were non-significant in both conditions from baseline to end of treatment, but significant improvements in psychosocial function, PTSD symptoms, and general psychopathology were observed over a 6-months follow-up period. Conclusion In the first randomized controlled trial for the treatment of complex dissociative disorders, stabilizing group treatment did not produce immediate superior outcomes. Treatment was shown to be associated with improvements in psychological functioning. Trial registration Clinical Trials (NCT02450617).
dc.language.isoeng
dc.rightsThe Author(s)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleGroup treatment for complex dissociative disorders: a randomized clinical trial
dc.typeJournal article
dc.date.updated2022-05-17T05:03:25Z
dc.creator.authorBækkelund, Harald
dc.creator.authorUlvenes, Pål
dc.creator.authorBoon-Langelaan, Suzette
dc.creator.authorArnevik, Espen A.
dc.identifier.doihttps://doi.org/10.1186/s12888-022-03970-8
dc.identifier.urnURN:NBN:no-96706
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/94155/1/12888_2022_Article_3970.pdf
dc.type.versionPublishedVersion
cristin.articleid338


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International